r/pharmaindustry

Specifically curious on quantitative data used to determine budgets, ie how the math maths.

Recently was at a medical conference. I get that you want something sexy to draw people to your booth, but some were SO over the top that it made me ill, especially when I would love to prescribe some of these drugs but my patients can’t afford them. We’re talking not thematically related driving simulators, a car, basketball arcades…etc.

Some had expensive setups but were somewhat more justifiable - eg one drug was extra with the plush carpet but it was eye catching and the VR headsets were educational for me and by extension patients. Another had a neat house set about detecting bronchiectasis.

I know they’re doing it to attract doctors to sell their products. But is their evidence that somehow a driving simulator is going to sway a prescriber more so than an educational VR headset?

Like keep the 12ft dragon but maybe drop the giant tree and use that budget for coupons to give patients discounts on their products?

And secondarily…this conference specifically mentioned trying to reduce their carbon footprint. Can conferences tell companies in their exhibit halls to tone it down?

With the AOM market supposed to explode through 2032, I'm seeing a lot of commercial and medical roles in Obesity?

Obesity Lead and Market access( alternatives channel) by novo, lily,Pfizer etc. with salary ranges around 210 to 381k base for manager level. Anyone have these gigs or know anyone who does and what do they do? Are these considered stable jobs in this job market, what do you guys think?

I’m looking for some honest career advice from people in pharma/industry or anyone who has been in a similar situation.

I’m a PharmD + MBA and turning 39 this year. I worked as a retail Pharmacy Manager for 3 years before transitioning into pharma/industry because I knew retail wasn’t the long-term path I wanted.
My entry into industry was through a CRA role. I started at a CRO in a junior-level CRA position, then eventually moved to the sponsor side and was promoted to Sr. CRA. I’ve now been in clinical research for about 3.5 years total.

The issue is… I feel financially stuck.

I currently make ~$149k/year, which I know is objectively a solid salary, but living in a VHCOL area with a stay-at-home spouse, growing family, mortgage, and large student loans has made things extremely tight. We’re essentially paycheck to paycheck, and I feel like I’m falling behind financially despite working incredibly hard and trying to progress my career aggressively.

What’s been frustrating is how slow advancement can feel in pharma, especially starting from the CRA route. Promotions seem to take forever, particularly on the CRO side, which is one reason I moved to sponsor. I’m highly motivated to move into higher-level roles such as Clinical Development, Clinical Scientist/CSE/CDD, Medical Affairs, or Regulatory, but sometimes it feels like the timeline to get there is painfully long.

Meanwhile, I look around and see:
Commercial pilots becoming captains in a few years making $400k+
MDs in pharma significantly out-earning PharmDs
Anesthesiologists making $500–600k+
Other careers with much faster financial acceleration

And honestly, it’s discouraging.

Seeing careers like commercial pilots — where someone can make compensation comparable to doctorate-level healthcare professionals in a fraction of the time — really makes me question whether I entered the wrong industry altogether. Sometimes it feels like I invested so much time, education, sacrifice, and debt into becoming a PharmD + MBA, yet the financial return and upward mobility feel much slower than I expected.

Don’t get me wrong — I genuinely do love pharma and working in a clinical research setting. I enjoy collaborating cross-functionally on clinical studies, contributing scientifically, and being involved in drug development. There are many aspects of this industry that I truly enjoy and find meaningful. But lately I can’t help but wonder… is the grass greener on the other side?

I value quality of life, intellectual stimulation, and ideally a mostly remote/WFH career. I don’t want this post to come across as “money is all I care about,” because it’s not. But I also want financial security for my family, the ability to invest for the future, travel the world with my kids, and enjoy life a bit more without constant financial pressure.

For those further along in pharma:
Does it eventually get significantly better financially?
Is staying the course in pharma worth it?
Would pursuing a Clinical Development/CSE/CDD or Medical Affairs path materially change compensation/QOL?
Am I underestimating how difficult it would be to pivot into something completely different like becoming a pilot or going to medical school at this stage?
If you were in my shoes, would you double down in pharma or consider a major career pivot?

I’d really appreciate any honest advice or perspective from people who have been there.

I’m a PharmD currently working as a Sr. CRA on the sponsor side with ~3.5 years of CRA experience total (CRO → sponsor progression).

I recently started a 6-month Clinical Science Expert / Clinical Development rotation because long term, the Clinical Development Director (CDD) path is probably my #1 career goal. However, my mentor — who is a CPM — recently reached out and offered to refer me for a newly opened CPM role at my company (essentially equivalent to a CTM role elsewhere).

So now I feel like I may have a dilemma.
On one hand, the CPM role is a real and immediate opportunity. On the other hand, accepting the role would most likely require me to stop the CSE/CDD rotation early, which could potentially close or significantly delay my pathway into Clinical Development.

I’d really appreciate insight from people who have worked in Clinical Operations, Clinical Development, or both.

A few things I’m trying to figure out:
Would taking a CPM/CTM role make it harder to transition into Clinical Development later, or could it actually help position me better internally?
Is the long-term compensation ceiling generally higher in Clinical Development compared to Operations?
Are PharmDs more valued within Clinical Development versus Operations, or is that less relevant once you’re already in industry?
If I stop the CSE/CDD rotation to take a CPM role, would I likely need to complete another development rotation later if I decide I still want the CDD path?

For those who have worked in either role:
Which did you find more intellectually stimulating?
Which had better work-life balance?
Which led to more burnout over time?

I want to be transparent that compensation and career growth do matter to me, but they are not the only factors. I genuinely enjoy the science and strategy side of drug development, which is why the CDD route appeals to me so much.

That said, I also understand that a CPM/CTM role is a strong opportunity and potentially a safer next step coming from a CRA background.

Part of my concern is whether taking the CPM route would unintentionally keep me more operations-focused long term, versus staying committed to development while I currently have momentum through this rotation.

At the same time, maybe I’m overthinking it and CPM/CTM operations is actually where I’m meant to be long term — and perhaps I’d end up enjoying it even more than I expect. That’s part of what makes this decision difficult.

All that being said, there’s also a chance I may not even get the CPM/CTM position if I apply, end up completing the CSE/CDD rotation successfully, and ultimately be exactly where I’m supposed to be career-wise. Maybe I just need to trust the process a bit more.

Would love honest perspectives from anyone who has navigated a similar crossroads.

I’m hiring at a smaller organization, and need to be more hands-on than any other organization I’ve worked with previously.

Outside of LinkedIn, Indeed, and company’s careers page, where else do your teams post open reqs for R&D candidates?

Why does the AI conversation in pharma brand planning seem to be stuck in two camps:

1. Fear: hallucinations, regulatory risk, AI-generated content reaching HCPs/patients.
2. Hype: faster decks, cleaner slides, summarized research.

Both are mostly focused on the wrong applications in my opinion. I've seen the highest-value AI uses in brand planning:

• Synthesizing ATUs, ad tracking, advisory boards, field feedback, and competitive intel into usable planning inputs
• Collecting asynchronous stakeholder input from field, access, advocacy, etc. and surfacing consensus/tensions
• Simulating executive challenge sessions by generating the most likely leadership questions before the review

None of this is customer-facing. None requires enterprise AI platforms. It mostly requires good prompts, judgment, and a planning process worth accelerating.

AI can speed up synthesis and pressure-testing. But it can't fix weak strategy, false departmental alignment, or teams operating from different assumptions about the patient.

Curious whether others are seeing meaningful AI use in commercial planning — or mostly just deck polishing.

I wrote a longer version on the structural problems in pharma brand planning and the diagnostic questions 2027 plans should answer. Happy to share if useful.